Health Net's Pharmacy Advisory Committee has updated the Injectable Medication HCPCS/DOFR Crosswalk effective November 17, 2026, adding 11 new injectable medications, 15 new biosimilars, 6 new generic medications, and making 27 updates to existing codes. The update includes 3 DOFR categorization corrections, 2 administrative changes, and 21 code description updates that will affect how injectable medications are billed and assigned to financial responsibility categories under the Health Net Provider Participation Agreement.
Get alerts when payers change rules like this one
We check Health Net and other payers every day and email you when a change matches your specialty and state.
01Billing team must access the complete policy update 26-1060 from the Provider Library to identify all specific injectable medication HCPCS codes affected (11 new codes, 27 updated codes, 15 new biosimilar codes, and 6 new generic codes).
02Update the billing system and charge master with the new and revised HCPCS codes and their corresponding DOFR category assignments to ensure claims are routed to the correct division of financial responsibility.
03Verify that all injectable medication billing reflects the correct DOFR categorization per the updated crosswalk.
04Failure to implement these changes will result in claims being billed to incorrect financial responsibility categories and potential claim denials or payment delays.
05Notify all providers and clinical staff of code changes impacting their specialties.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.